LLainomedical — Pre-seed (estimated) · €220K
Lainomedical closed a €220,000 capital increase to speed up development and commercial launch of Nebulok, which was planned for late 2021. Its existing shareholders took part: founders Juanjo and Iñaki Salegui, CEO Francesc Paris, and Carlos Yañez y Orza. The company had support from BIC Gipuzkoa and the Basque Government and went through the MassChallenge and Ship2B accelerators, but none of these were part of the round.
Lead unknown
RoundPre-seed (estimated)
Announced24 Nov 2020
CitySan Sebastián
SectorHealthtech & Bio · Medtech
Source
C
C
The company
Investors
No investors were disclosed for this round.